Rainbow Rare Earths Maps High-Margin, Delayed Growth Path

Rainbow Rare Earths ((GB:RBW)) has held its Q2 earnings call. Read on for the main highlights of the call.

Rainbow Rare Earths’ latest earnings call struck an upbeat tone, with management emphasizing strong project economics, successful pilot operations and a growing roster of strategic partners. While they acknowledged delays and funding dependence, executives argued that process optimizations and derisked flowsheets now support a lower‑cost path to production with material upside to returns if rare earth prices strengthen.

Phalaborwa: High-Margin South African Flagship

Phalaborwa remains the cornerstone asset, projected to deliver about $181M in annual EBITDA over a 16‑year life using a conservative NdPr price of $110/kg. Management stressed that NdPr traded nearer $140/kg earlier in 2026, implying meaningful upside to cash flow and underscoring the project’s appeal as a rare earths producer with significant operating leverage.

Uberaba: Brazilian Growth Engine With >45% IRR

The newly detailed Uberaba assessment in Brazil points to an NPV around $1B at a 10% discount rate and an IRR above 45%. With EBITDA of roughly $217M per year, margins north of 70%, CapEx of about $280M and a mine life exceeding 30 years, Uberaba’s higher grade of roughly 5,100 ppm TREO enhances Rainbow’s long‑term growth profile.

Low CapEx, Top-Tier Margins vs Global Peers

Taken together, Phalaborwa and Uberaba are positioned as low‑capital‑intensity, high‑margin assets at the top end of the global cost curve rankings. Management referenced Argus Media analysis showing Phalaborwa as the highest‑margin rare earth project in development at 2024 prices and suggested Rainbow could even undercut Chinese costs for separated rare earths in Western markets.

Pilot Plant Validates Flowsheet at Industrial Scale

A 24/7 continuous pilot at Mintek in South Africa is producing around one kilogram per day of mixed rare earth hydroxide, which is a commercial‑scale intermediate rather than a lab‑scale output. The company highlighted the successful continuous ion exchange stage, which slashed volumetric flows from roughly 340 cubic meters per hour to 40–50, and further down to just 3–4 cubic meters per hour into solvent extraction.

Process Optimizations Drive Cost and CapEx Savings

Operational tweaks have trimmed the front‑end leach stages from three to two while raising leach temperatures, cutting resin residence time from 32 hours to just eight hours. Management said this 75% reduction in contact time materially lowers tankage, steelwork and earthworks requirements, helping keep capital spending within earlier guidance and supporting the goal of industry‑leading margins.

Strategic Partners and Fresh Capital Strengthen Position

The call underlined growing strategic support, including a committed $50M project equity contribution from a major development finance entity at final investment decision. Rainbow also benefits from its partnership with Mosaic in Brazil, backing from a supportive investor base and a new relationship with Traxys, while a recent $14.6M equity raise at 20p was largely funded by U.S. investors.

Runway Extended, With Tight Grip on Costs

With a monthly cash burn of about $400k, the $14.6M raise gives the company close to 35 months of financial runway at current spending levels. Management estimates that the remaining cost to complete the Phalaborwa definitive feasibility study, environmental approvals and permitting is roughly $4–4.5M, suggesting ample liquidity to reach key de‑risking milestones.

ESG Edge From Turning Waste Into Revenue

Both projects are based on recovering rare earths from existing phosphogypsum waste stacks at brownfield fertilizer sites, rather than opening new greenfield mines. Management highlighted that this model avoids community displacement, aims to remediate legacy waste stacks with lined reclamation and meaningfully reduces the environmental footprint compared with traditional rare earth mining.

Timeline Slippage After Technology Pivot

Management acknowledged that a pivot away from an initially planned separation technology has pushed the schedule back by roughly a year. Phalaborwa’s first production is now targeted for late 2028 or early 2029, while Uberaba is expected to follow around 2030, reflecting the time needed to validate solvent extraction at scale and incorporate it into the development plan.

Technology Partner Setback Raised Execution Risks

The delay stems from an early technology partner whose claims around continuous ion chromatography could not be backed by robust data, forcing Rainbow to repatriate pilot work and redesign the separation route. While the company believes its new flowsheet is more robust, this episode highlighted the execution and schedule risk inherent in pioneering new processing routes at commercial scale.

Exposure to Rare Earth Prices and Market Dynamics

Management was candid that project economics remain sensitive to rare earth pricing and cited recent industry examples where producers struggled at 2024 price levels. While current models assume conservative price decks and point to upside at higher NdPr levels, the ability to capture premium Western pricing instead of lower Chinese benchmarks will be critical for realizing the full margin potential.

Financing Structure Relies on Project Debt Markets

The company plans to fund development with roughly two‑thirds debt and one‑third equity, making access to project finance a key swing factor for timelines and shareholder dilution. Even with a strengthened balance sheet today, Rainbow must still navigate volatile capital markets to secure construction funding, introducing financing risk ahead of the build‑out of both flagship projects.

Valuation Discount and Potential Move to U.S. Market

Management argued that the shares trade at a steep discount to rare earth peers despite what they describe as superior project margins and de‑risking progress. They are evaluating a potential U.S. listing to deepen liquidity and help close the valuation gap, though the current discount may itself limit strategic flexibility and weigh on investor sentiment in the near term.

Scale-Up Risk Still to Be Proven in the Field

Although pilot runs show minimal resin degradation and low impurity bleed‑through, management conceded that scaling continuous ion exchange, precipitation and solvent extraction to full commercial levels remains a key uncertainty. Current assumptions include conservative resin replacement every five years and low operating costs, but investors will look for performance data closer to nameplate capacity.

Guidance: Clear Roadmap, Strong Metrics but Long Lead Time

Looking ahead, management aims to complete the Phalaborwa definitive feasibility study by the end of 2026, reach final investment decision by late 2027 and begin construction in 2028 with first production by late 2028 or early 2029, while Uberaba targets 2030. Guidance reiterates CapEx of about $320M for Phalaborwa and $280M for Uberaba, with combined potential EBITDA around $400M annually and attractive returns supported by high grades and optimized process flows.

Rainbow Rare Earths’ call painted a picture of two rare earth projects with standout economics, tangible pilot‑plant validation and growing institutional backing, offset by a longer road to first production and exposure to commodity and financing cycles. For investors willing to tolerate development risk and a multi‑year timeline, the company is positioning itself as a potential low‑cost Western supplier in a strategically important sector.